Skip to main content

Table 3 Risk categorization of chemotherapeutic drugs based on environmental exposure data between 2013 and 2018

From: Chemotherapeutic drugs in Lebanese surface waters: estimation of population exposure and identification of high-risk drugs

CLASS IA

Class IIA

Class III

CLASS IV

Mycophenolate mofetil (2013–2014, 2016) Mycophenolic acid equivalent (2016)

Azathioprine (2013–2015, 2017–2018) Capecitibine Hydroxycarbamide Mycophenolate mofetil (2015, 2017, 2018)

Mycophenolic acid (2014–2018) Mycophenolic acid equivalent (2013–2015, 2017–2018)

5-fluorouracil equivalent

Mycophenolic acid (2013)

Tamoxifen (2015–2018)

Imatinib (2013–2016)

Azathioprine (2016)

Ciclosporin (2014)

Imatinib (2017–2018)

Afatinib

Imatinib

Alectinib

Anastrazole

Apremilast

Axitinib

Azacitidine

Baricitinib

Bendamustine HCl

Bicalutamide Bleomycin

Busulfan

Cabazitaxel

Carboplatin Carfilzomib

Ciclosporin (2013,2015–2018)

Cisplatin

Clofarabine

Cladribine

Crizotinib

Cyclophosphamide

Cytarabine

Dacarbazine

Dasatinib

Decitabine

Degarelix

Docetaxel

Doxorubicin

Enzalutamide

Epirubicin HCl

Eribulin mesylate

Erlotinib

Etoposide

Everolimus

Exemestane

Fingolimod

Fludarabine

Fluorouracil

Fulvestrant

Gefitinib

Goserelin

Ibrutinib

Idarubicin HCl

Ifosfamide

Irinotecan HCl

Lapatinib ditosylat

Leflunomide

Lenalidomide

Lenvatinib

Letrozole

Leuprorelin

Mercaptopurine

Mitoxantrone

Nilotinib

Nintedanib

Osimertinib

Paclitaxel

Palbociclib

Pazopanib HCl

Pemetrexed

Plerixafor Methotrexate equivalent

Pomalidomide

Pralatrexate

Regorafenib

Ribociclib

Ruxolitinib

Sirolimus

Sorafenib

Sunitinib maleate

Tacrolimus monohydrate

Temozolomide

Teriflunomide

Thalidomide

Tofacitinib

Trabectedin

Trifluridine

Triptorelin

Vemurafenib

Venetoclax

Vincristine sulfate

Vinflumine

Vinorelbine

Vismodegib

Oxaliplatin

Gemcitabine

Methotrexate

Tamoxifen (2013–2014)

Methotrexate equivalent

Docetaxel equivalent

Doxorubicin equivalent

Goserelin equivalent